MX2018012904A - Uso de beta-agonistas del receptor de la hormona tiroidea. - Google Patents

Uso de beta-agonistas del receptor de la hormona tiroidea.

Info

Publication number
MX2018012904A
MX2018012904A MX2018012904A MX2018012904A MX2018012904A MX 2018012904 A MX2018012904 A MX 2018012904A MX 2018012904 A MX2018012904 A MX 2018012904A MX 2018012904 A MX2018012904 A MX 2018012904A MX 2018012904 A MX2018012904 A MX 2018012904A
Authority
MX
Mexico
Prior art keywords
agonists
thyroid beta
thyroid
beta
treating
Prior art date
Application number
MX2018012904A
Other languages
English (en)
Inventor
Lian Brian
Hanley Rochelle
Dinerman Misha
Original Assignee
Viking Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viking Therapeutics Inc filed Critical Viking Therapeutics Inc
Publication of MX2018012904A publication Critical patent/MX2018012904A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)

Abstract

La presente invención se refiere a métodos útiles para tratar la adrenoleucodistrofia enlazada a X.
MX2018012904A 2016-04-22 2017-04-24 Uso de beta-agonistas del receptor de la hormona tiroidea. MX2018012904A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662326431P 2016-04-22 2016-04-22
PCT/US2017/029102 WO2017185083A1 (en) 2016-04-22 2017-04-24 Use of thyroid beta-agonists

Publications (1)

Publication Number Publication Date
MX2018012904A true MX2018012904A (es) 2019-01-31

Family

ID=60117062

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018012904A MX2018012904A (es) 2016-04-22 2017-04-24 Uso de beta-agonistas del receptor de la hormona tiroidea.

Country Status (10)

Country Link
US (1) US20190134069A1 (es)
EP (1) EP3445372A4 (es)
JP (1) JP2019515915A (es)
KR (1) KR102407053B1 (es)
CN (3) CN110200978B (es)
AU (2) AU2017252122B2 (es)
BR (1) BR112018071559B1 (es)
CA (1) CA3021677A1 (es)
MX (1) MX2018012904A (es)
WO (1) WO2017185083A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6931042B2 (ja) 2016-04-22 2021-09-01 バイキング セラピューティクス，インコーポレーテッド 甲状腺ベータアゴニストの使用
US11752161B2 (en) 2020-03-27 2023-09-12 Gannex Pharma Co., Ltd. Pharmaceutical compositions, method of making and method of using thereof
WO2023245055A1 (en) * 2022-06-15 2023-12-21 Viking Therapeutics, Inc. Thyroid beta-agonist dosing regimens for the treatment of x-ald

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040091455A1 (en) * 2002-10-31 2004-05-13 Zeldis Jerome B. Methods of using and compositions comprising immunomodulatory compounds for treatment and management of macular degeneration
CA2543132A1 (en) * 2003-10-23 2005-05-19 Celgene Corporation Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain
CA2584845C (en) * 2004-12-08 2009-02-17 Sirion Therapeutics, Inc. Methods, assays and compositions for treating retinol-related diseases
US20090042857A1 (en) * 2006-02-20 2009-02-12 Masuo Yamaoka Novel Pharmaceutical
WO2011038207A1 (en) * 2009-09-25 2011-03-31 Metabasis Therapeutics, Inc. Phosphorus-containing thyroid hormone receptor agonists and methods of use
US8575207B2 (en) * 2010-08-16 2013-11-05 Allergan, Inc. Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
JP2016517883A (ja) * 2013-05-03 2016-06-20 オレゴン ヘルス アンド サイエンス ユニバーシティー Ｘ連鎖副腎白質ジストロフィーの処置におけるソベチロムの使用
US9701650B2 (en) * 2015-02-20 2017-07-11 Oregon Health & Science University Derivatives of sobetirome
BR112018015561B1 (pt) * 2016-02-29 2023-03-28 Philip Morris Products S.A. Recipiente com tampa articulada e molde
KR102331596B1 (ko) * 2016-05-18 2021-11-25 오레곤 헬스 앤드 사이언스 유니버시티 소베티롬의 유도체

Also Published As

Publication number Publication date
EP3445372A1 (en) 2019-02-27
AU2023202321A1 (en) 2023-05-11
WO2017185083A1 (en) 2017-10-26
CN113730421A (zh) 2021-12-03
AU2017252122B2 (en) 2023-02-09
CN110200978A (zh) 2019-09-06
EP3445372A4 (en) 2020-03-25
KR20190017748A (ko) 2019-02-20
AU2017252122A1 (en) 2018-11-15
KR102407053B1 (ko) 2022-06-10
CN110200978B (zh) 2023-10-31
BR112018071559A2 (pt) 2019-05-14
CA3021677A1 (en) 2017-10-26
BR112018071559B1 (pt) 2024-02-06
JP2019515915A (ja) 2019-06-13
CN109641003A (zh) 2019-04-16
US20190134069A1 (en) 2019-05-09

Similar Documents

Publication Publication Date Title
PH12020550781A1 (en) Anti-jagged1 antibodies and methods of use
PH12017500877A1 (en) ANTI-CD79b ANTIBODIES AND METHODS OF USE
PH12016501894B1 (en) Anti-ox40 antibodies and methods of use
MX2017005920A (es) Anticuerpos anti-tim3 y metodos de uso.
PH12017500322A1 (en) Anti-her2 antibodies and immunoconjugates
MX2017003022A (es) Anticuerpos anti-cll-1 e inmunoconjugados.
GB2556286A (en) Programmable voltage reference
MX2017006094A (es) Anticuerpos anti-interleucina-33 y sus usos.
MX2017001981A (es) Inhibidores de diana de rapamicina en celulas de mamifero de complejo 1 (mtorc1).
MX2016015162A (es) Anticuerpos anti - gpc3 e inmunoconjugados.
MX2016009858A (es) Fusiones anti proteína convertasa subtilisina/kexina tipo 9 (anti-pcsk9)n péptido 1 similar a glucagón (glp-1) y métodos de uso.
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
MX2020012893A (es) Formulaciones de proteinas.
PH12017501022A1 (en) Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same
MX2018012900A (es) Uso de beta-agonistas del receptor de la hormona tiroidea.
MX2016016233A (es) Anticuerpos anti-lgr5 y sus usos.
MX2018012904A (es) Uso de beta-agonistas del receptor de la hormona tiroidea.
MX2016015280A (es) Anticuerpos anti-bromodesoxiuridina(brdu) y metodos de uso.
EP3094347A4 (en) Methods for enhancing the delivery of active agents
WO2016040313A3 (en) Methods of treating cancer comprising administering a ppar-gamma agonist
MX2016009541A (es) Metodo para tratar vajilla.
NZ744340A (en) Anti-jagged1 antibodies and methods of use
IN2014CH00872A (es)
UA98223U (ru) Высокоэнергетические эко пеллеты